We are live on ! Find out more
SAM

Silphium Asset Management Portfolio holdings

AUM $264M
1-Year Est. Return 19.59%
This Fund
S&P 500
This Quarter Est. Return
+26.72%
1 Year Est. Return
+19.59%
3 Year Est. Return
+106.9%
5 Year Est. Return
+319.93%
10 Year Est. Return
AUM
$100M
AUM Growth
-$11.1M
Cap. Flow
-$18.3M
Cap. Flow %
-18.27%
Top 10 Hldgs %
64.53%
Holding
61
New
19
Increased
6
Reduced
5
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 35.61%
2 Financials 16.49%
3 Technology 14.6%
4 Industrials 9.95%
5 Energy 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
51
Xylem
XYL
$28.5B
-19,549
Closed -$1.71M
VMW
52
DELISTED
VMware, Inc
VMW
-33,000
Closed -$3.51M
AUY
53
DELISTED
Yamana Gold, Inc.
AUY
-100,000
Closed -$453K
SWCH
54
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-200,000
Closed -$6.74M
ZEN
55
DELISTED
ZENDESK INC
ZEN
-38,577
Closed -$2.94M
TEN
56
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-50,000
Closed -$870K
TWTR
57
DELISTED
Twitter, Inc.
TWTR
-250,000
Closed -$11M
GBT
58
DELISTED
Global Blood Therapeutics, Inc.
GBT
-200,000
Closed -$13.6M
TRQ
59
DELISTED
Turquoise Hill Resources Ltd
TRQ
-25,000
Closed -$739K
NLSN
60
DELISTED
Nielsen Holdings plc
NLSN
-450,000
Closed -$12.5M
FBC
61
DELISTED
Flagstar Bancorp, Inc. New
FBC
-135,045
Closed -$4.51M

Similar funds

Silphium Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Silphium Asset Management held 61 positions worth $100M, down 10% from $111M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Silphium Asset Management withdrew a net $18.3M in Q4 2022, closing 21 positions and reducing 5 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $13.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

Against the trend, Silphium Asset Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $15.9M.

  • Silphium Asset Management's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 140,000 shares worth $15.9M.
  • Silphium Asset Management added most to Cowen Inc. Class A Common Stock in Q4 2022, an estimated $7.73M increase.
  • Silphium Asset Management's biggest Q4 2022 reduction was Ulta Beauty, cutting an estimated $1.29M.
  • Silphium Asset Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $13.6M.
  • Silphium Asset Management's ten largest holdings make up 65% of its $100M portfolio in Q4 2022.
  • Silphium Asset Management opened 19 new positions and closed 21 in Q4 2022.
  • Silphium Asset Management's portfolio value fell 10% quarter-over-quarter to $100M.

Based on Silphium Asset Management's 13F filing for Q4 2022, filed 30 Jan 2025.